Suppr超能文献

钠(+)/氯(-)偶联神经递质转运体的逆向作用 - 为什么安非他命需要两个才能共舞。

The reverse operation of Na(+)/Cl(-)-coupled neurotransmitter transporters--why amphetamines take two to tango.

机构信息

Institute of Pharmacology, Center for Biomolecular Medicine and Pharmacology, Medical University of Vienna, Vienna, Austria.

出版信息

J Neurochem. 2010 Jan;112(2):340-55. doi: 10.1111/j.1471-4159.2009.06474.x. Epub 2009 Nov 5.

Abstract

Sodium-chloride coupled neurotransmitter transporters achieve reuptake of their physiological substrate by exploiting the pre-existing sodium-gradient across the cellular membrane. This terminates the action of previously released substrate in the synaptic cleft. However, a change of the transmembrane ionic gradients or specific binding of some psychostimulant drugs to these proteins, like amphetamine and its derivatives, induce reverse operation of neurotransmitter:sodium symporters. This effect eventually leads to an increase in the synaptic concentration of non-exocytotically released neurotransmitters [and - in the case of the norepinephrine transporters, underlies the well-known indirect sympathomimetic activity]. While this action has long been appreciated, the underlying mechanistic details have been surprisingly difficult to understand. Some aspects can be resolved by incorporating insights into the oligomeric nature of transporters, into the nature of the accompanying ion fluxes, and changes in protein kinase activities.

摘要

钠-氯共转运体通过利用细胞膜上预先存在的钠离子梯度来实现其生理底物的再摄取。这终止了先前在突触间隙中释放的底物的作用。然而,跨膜离子梯度的变化或某些精神兴奋剂药物(如安非他命及其衍生物)与这些蛋白质的特异性结合,会诱导神经递质:钠同向转运体的反向操作。这种效应最终导致非胞吐释放的神经递质在突触中的浓度增加[在去甲肾上腺素转运体的情况下,这是众所周知的间接拟交感神经活性的基础]。虽然这种作用早已被人们所认识,但背后的机制细节却令人惊讶地难以理解。通过将转运体的寡聚性质、伴随的离子通量的性质以及蛋白激酶活性的变化纳入考虑,可以解决其中的一些方面。

相似文献

1
The reverse operation of Na(+)/Cl(-)-coupled neurotransmitter transporters--why amphetamines take two to tango.
J Neurochem. 2010 Jan;112(2):340-55. doi: 10.1111/j.1471-4159.2009.06474.x. Epub 2009 Nov 5.
3
Pharmacology of Drugs Used as Stimulants.
J Clin Pharmacol. 2021 Aug;61 Suppl 2:S53-S69. doi: 10.1002/jcph.1918.
4
Regulated expression and function of the somatodendritic catecholamine neurotransmitter transporters.
J Pharmacol Sci. 2005 Oct;99(2):121-7. doi: 10.1254/jphs.cpj05003x. Epub 2005 Oct 8.
5
Psychostimulants and monoamine transporters: upsetting the balance.
Curr Opin Pharmacol. 2005 Feb;5(1):94-100. doi: 10.1016/j.coph.2004.09.005.
6
Neurotransmitter transporters: structure meets function.
Structure. 2013 May 7;21(5):694-705. doi: 10.1016/j.str.2013.03.002.
7
Review. The molecular logic of sodium-coupled neurotransmitter transporters.
Philos Trans R Soc Lond B Biol Sci. 2009 Jan 27;364(1514):149-54. doi: 10.1098/rstb.2008.0181.
8
Neurotransmitter transporters in schistosomes: structure, function and prospects for drug discovery.
Parasitol Int. 2013 Dec;62(6):629-38. doi: 10.1016/j.parint.2013.06.003. Epub 2013 Jun 22.
10
How LeuT shapes our understanding of the mechanisms of sodium-coupled neurotransmitter transporters.
J Physiol. 2014 Mar 1;592(5):863-9. doi: 10.1113/jphysiol.2013.259051. Epub 2013 Jul 22.

引用本文的文献

1
Ecstasy, molly, MDMA: What health practitioners need to know about this common recreational drug.
Dis Mon. 2025 Mar;71(3):101851. doi: 10.1016/j.disamonth.2024.101851. Epub 2025 Jan 14.
3
E-cigarettes may serve as a gateway to conventional cigarettes and other addictive drugs.
Adv Drug Alcohol Res. 2023 Jun 30;3:11345. doi: 10.3389/adar.2023.11345. eCollection 2023.
4
Development and validation of an automated microfluidic perfusion platform for parallelized screening of compounds in vitro.
Basic Clin Pharmacol Toxicol. 2023 Nov;133(5):535-547. doi: 10.1111/bcpt.13940. Epub 2023 Sep 17.
6
Combined Optogenetic Approaches Reveal Quantitative Dynamics of Endogenous Noradrenergic Transmission in the Brain.
iScience. 2020 Oct 21;23(11):101710. doi: 10.1016/j.isci.2020.101710. eCollection 2020 Nov 20.
7
SLC6 transporter oligomerization.
J Neurochem. 2021 May;157(4):919-929. doi: 10.1111/jnc.15145. Epub 2020 Aug 28.
8
Structure Modeling of the Norepinephrine Transporter.
Biomolecules. 2020 Jan 7;10(1):102. doi: 10.3390/biom10010102.
9
A Perspective: Active Role of Lipids in Neurotransmitter Dynamics.
Mol Neurobiol. 2020 Feb;57(2):910-925. doi: 10.1007/s12035-019-01775-7. Epub 2019 Oct 8.
10
Trimerization of dopamine transporter triggered by AIM-100 binding: Molecular mechanism and effect of mutations.
Neuropharmacology. 2019 Dec 15;161:107676. doi: 10.1016/j.neuropharm.2019.107676. Epub 2019 Jun 20.

本文引用的文献

1
Visualization of dopamine transporter trafficking in live neurons by use of fluorescent cocaine analogs.
J Neurosci. 2009 May 27;29(21):6794-808. doi: 10.1523/JNEUROSCI.4177-08.2009.
5
Molecular basis of transport and regulation in the Na(+)/betaine symporter BetP.
Nature. 2009 Mar 5;458(7234):47-52. doi: 10.1038/nature07819.
6
A closer look at amphetamine-induced reverse transport and trafficking of the dopamine and norepinephrine transporters.
Mol Neurobiol. 2009 Apr;39(2):73-80. doi: 10.1007/s12035-009-8053-4. Epub 2009 Feb 6.
7
Proline-directed phosphorylation of the dopamine transporter N-terminal domain.
Biochemistry. 2009 Feb 10;48(5):1067-76. doi: 10.1021/bi801696n.
9
A competitive inhibitor traps LeuT in an open-to-out conformation.
Science. 2008 Dec 12;322(5908):1655-61. doi: 10.1126/science.1166777.
10
LeuT: a prokaryotic stepping stone on the way to a eukaryotic neurotransmitter transporter structure.
Channels (Austin). 2008 Sep-Oct;2(5):380-9. doi: 10.4161/chan.2.5.6904.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验